Objective: To test if posterior retroperitoneoscopic adrenalectomy (PRA) is superior to lateral transperitoneal laparoscopic adrenalectomy (LTLA). Background: Most popular LTLA has been recently challenged by an increasing popularity of PRA, which is believed by many surgeons (not evidencebased) as superior to LTLA in the treatment of small and benign adrenal tumors. Methods: Participants were assigned randomly to PRA or LTLA and followed for 5 years after surgery. The primary endpoint was the duration of surgery. Secondary endpoints were blood loss, conversion rate, postoperative recovery, morbidity, and costs. Results: Sixty-five patients were included, of whom 61 (PRA 30, LTLA 31) completed the 5-year follow-up. The following differences were identified in favor of PRA vs LTLA: shorter duration of surgery (50.8 vs 77.3 minutes), lower intraoperative blood loss (52.7 vs 97.8 mL), diminished pain intensity within 48 hours postoperatively, lower prevalence of shoulder-tip pain (3.0% vs 37.5%), shorter time to oral intake (4.4 vs 7.3 hours), shorter time to ambulation (6.1 vs 11.5 hours), shorter length of hospital stay, and lower cost (1728 € vs 2315 €), respectively (P < 0.001 for all). No differences were noted in conversion rate or morbidity except for herniation occurring more often after LTLA than PRA (16.1% vs 0%, P = 0.022) and need for hernia repair (12.9% vs 0%, P = 0.050), respectively. Conclusions: Both approaches were equally safe. However, outcomes of PRA operations were superior to LTLA in terms of shorter surgery duration, lower blood loss, lower postoperative pain, faster recovery, improved cost-effectiveness, and abolished risk of surgical access site herniation. Registration number: NCT01959711 (http://www.clinicaltrials.gov).
Interventions
All operations in this study were unilateral total adrenalectomies and were carried out by a single experienced endocrine surgeon (M.B.) under general anesthesia. The same anesthesia protocol was used in all the patients. The surgeon (M.B.) completed a training program in LTLA during his visiting observership in 2002 in the Mount Sinai School of Medicine, Minimally Invasive Surgery Center (New York) headed by M. Gagner, and in PRA during his visiting observership in 2003 in the Department of Surgery and Center for Minimally Invasive Surgery, University of Essen (Essen, Germany) headed by M. Walz. The surgeon (M.B.) has been performing adrenalectomies by either PRA or LTLA since 2003, and before the starting date of this randomized study, he gained proficiency with both approaches on the basis of 107 consecutive adrenalectomies (50 PRA and 57 LTLA). It is important to note that after clinical visit in Essen, the surgeon (M.B.) was continuously supervised, including the assistance of an experienced surgeon (M.K.W.) during the initial 3 cases of PRA operated on in Krakow. 16 PRA operations were performed using the Walz's technique in the patient in the prone position with flexed hip joints on a hollowed out mattress, [13] [14] [15] [16] whereas LTLA operations were performed employing the Gagner's technique in the patient in the lateral decubitus position. 3, 4 Another major difference between these 2 techniques is that CO 2 insufflation pressures are higher in PRA-undergoing patients (20-25 mm Hg) versus LTLA-undergoing patients (12 mm Hg). The detailed surgical technique of both PRA and LTLA has been described in the supplementary material available online. Intraoperative dissection and hemostasis was achieved in both groups by the ultrasonic harmonic shears (LCSC5 or ACE; Ultracision; Ethicon EndoSurgery, Somerville, NJ). In both groups, the mobilized adrenal gland was removed through the trocar port with a latex endocath bag (Endocatch, USSC Norwalk, CT). In selected cases, the skin incision was extended to allow for removing the intact surgical material (morcellation was not used). The same fascia closure technique was used for PRA and LTLA operations using interrupted absorbable sutures and a BERCI Facial Closing Instrument (STORZ, Tutlingen, Germany) for all 10-mm trocar sites, whereas 5-mm trocar sites were not closed. Drainage of the wounds was not used. The surgical specimen was then referred to pathological examination.
Outcomes
The primary endpoint was duration of surgery. The secondary endpoints were intraoperative blood loss, conversion rate, postoperative pain, prevalence of shoulder-tip pain, additional analgesia requests, nausea and vomiting, time to oral intake, time to ambulation, length of hospital stay, total cost of the operation, postoperative complications (including long-term surgical access site herniation and need for hernia repair), and in cases of surgery for hormonally active tumors also biochemical and clinical cure rate during 5-year follow-up.
Follow-up
Neither of the patients, nurses, or outcomes-assessing clinical investigators knew the relevant group assignment. Both the abdomen and lumbar region on the side of the operation were covered with an opaque, large, and air-permeable but water-resistant dressing to conceal the site of the surgical access for the initial 3 postsurgery days. Surgery was undertaken on the next day after admission and an overnight hospital stay was mandatory for all the patients.
The following data were collected by independent clinical investigators during the study: duration of surgery, intraoperative blood loss, conversion rate, postoperative pain, prevalence of shoulder-tip pain, additional analgesia requests, nausea and vomiting, time to oral intake of clear liquids and solid diet, time to ambulation, length and cost of hospital stay, morbidity, biochemical laboratory values, and clinical disease recovery data. The patients were encouraged to be mobilized and to drink and eat soon after returning from the recovery room. A clear liquid diet was started when the patient was awake and alert without nausea or vomiting. As soon as the patient tolerated 750 mL of clear liquids, the diet was advanced to a solid diet. In case of uneventful postoperative recovery, the patient was discharged after tolerating 3 solid meals, when normal bowel movements were present and body temperature was normal.
The prevalence of postoperative complications was evaluated during hospitalization and visits at the outpatient surgical department scheduled at 7 days and 1, 12, 24, 36, 48, and 60 months after the operation. Surgical complications were classified according to the Dindo-Clavien classification. 27 Herniation was assessed on follow-up visits by a physical examination performed by the attending surgeons. In cases of bulging, local pain and/or tenderness and any equivocal finding, the patients underwent an ultrasonography using a 7.5 MHz linear-array probe to confirm or rule out the existence of a hernia.
Duration of surgery was calculated from skin incision to skin closure. Intraoperative blood loss was calculated on the basis of hematocrit assessment in the saline fluid used for irrigation in relation to the blood hematocrit. Pain intensity was assessed using the visual analog scale (VAS) at 4, 8, 12, 24, and 48 hours postoperatively. The patients were aware that the scale served to analyze the intensity of pain alone, including shoulder-tip pain if present, and was not a representation of their generalized postoperative discomfort. Nurse-controlled analgesia (NCA) protocol was used in this study. Paracetamol (Polfa, Lódz, Poland) was used for standard analgesia, 1 g per single dose orally every 6 hours, up to 4 g/d. Any additional NCA request was recorded. For NCA requests, ketoprofen (Sandoz, Warsaw, Poland) was used as a painkiller, the dose being 0.1 g orally, whereas pethidine (Polfa, Warsaw, Poland) was used in case of persistent pain relief requests, the dose being 1 mg per kg IM.
The cost-effectiveness analysis was performed using an official in-hospital price list for medical procedures. The costs included (in EUR) the following: €10 per minute for the use of operating theater, €5 per minute for anesthesia, €250 for the use of laparoscopic/endoscopic equipment, €350 for the use of ultrasonic harmonic shears, and €125 per day of hospitalization.
In cases of surgery for hormonally active tumors, serum metanephrines, aldosterone, potassium, and cortisole values were measured as well as blood pressure, the number and/or dose of antihypertensive medications, and the need for substitution therapy for adrenocortical hormones at 1, 12, 24, 36, 48, and 60 months after the operation. All the data were entered into a dedicated spreadsheet (Microsoft Excel 2002, Microsoft Corporation, San Jose, CA).
Sample Size
For a sample size calculation, an assumption was made that a 20% reduction in duration of surgery represents a clinically relevant difference. To detect this, it was calculated that 24 patients would be required in each treatment arm to give the study a power of 90%. Anticipating a 25% loss to follow-up, 32 patients per arm were required in the study. numbered and sealed envelopes that were stored in the operating theater. An envelope containing the allocation was added to the patient's file in the operating room. The envelope was opened and the surgeon performed the assigned intervention.
Statistical Methods
Data are presented as mean with 95% confidence interval (CI) unless stated otherwise. The analysis of primary and secondary variables was performed on an intention-to-treat basis. The statistical significance of categorical variables was evaluated by the χ 2 test, whereas the Student t test was used for the analysis of continuous variables. The postoperative pain scores assessed using VAS were treated as parametric. Odds ratios (ORs) with 95% CI were calculated for categorical variables. Univariable logistic regression analyses were performed to identify predictors of the risk of prolonged duration of surgery of more than 90 minutes. Continuous variables were dichotomized. Variables considered for the univariable analysis were gender, side of the tumor, tumor size, body mass index (BMI), functioning of the tumor, previous abdominal surgery, and surgical approach. Variables with P < 0.200 in the univariable analysis were included in a forward stepwise multiple logistic regression model. P < 0.050 was considered significant in the final prediction model. Statistical analyses were performed with Statistica 10 for Windows (StatSoft, Krakow, Poland).
RESULTS
Eighty-eight patients were referred for adrenal surgery and were potential candidates for the study. Twenty patients did not meet the inclusion criteria and 3 refused to participate, leaving 65 patients with complete short-term follow-up (33 in the PRA and 32 in the LTLA group) and 61 patients who were followed-up for 5 years (30 in the PRA and 31 in the LTLA group) as shown in Fig. 1 . There were no significant differences in baseline characteristics between the 2 groups ( Table 1) . 
Primary Endpoints
Duration of PRA was significantly shorter than LTLA: 50.7 minutes (44.9-56.6) versus 77.3 minutes (71.1-83.6), P < 0.001, respectively ( Table 2) . On univariable analysis, a left-sided operation, BMI of more than 30 kg/m 2 , and LTLA approach predicted the prolonged duration of surgery of more than 90 minutes. However, on multivariable analysis, BMI of more than 30 kg/m 2 (OR = 8.460, CI: 1.764-32,176; P = 0.002) and LTLA approach (OR = 9.138, CI: 2.056-57.412; P = 0.002) were independent predictors of duration of surgery of more than 90 minutes (Table 3 ).
Secondary Endpoints
The following short-term secondary endpoints were identified in favor of PRA versus LTLA: lower intraoperative blood loss (P < 0.001); diminished pain intensity both at rest and on movements at 4, 8, 12, 24, and 48 hours postoperatively (P < 0.001); lower prevalence of shoulder-tip pain (P < 0.001); less frequent additional analgesia requests (<0.001); lower prevalence of nausea (P = 0.029) but not vomiting (P = 0.203); shorter time to oral intake (P < 0.001); shorter time to ambulation (P < 0.001); shorter length of hospital stay (P < 0.001); and lower cost (P < 0.001), respectively. No differences were noted in conversion rate (P = 1.000) or short-term morbidity (P = 0.221). Only 1 patient after left-sided LTLA for glucocorticoid adrenal adenoma (40 mm in size, BMI 38.5) had an episode of hypertension with systolic blood pressure (SBP) of 210 mm Hg during his stay in the recovery room, which necessitated emergency IV medication (25 mg of urapidyl, Takeda Pharma, Poland; furosemide 40 mg, Fresenius Kabi, Poland) to stabilize SBP below 140 mm Hg, whereas all the other patients operated on for hormonally active tumors had no episodes of hypertension with SBP of more than 160 mm Hg. Only 1 Grade III complication was noted during the study in a patient after right-sided LTLA for glucocorticoid adrenal adenoma (55 mm in size, BMI 39.7). To remove this tumor, both the fascia and skin incision were widened and wound dehiscence occurred on postoperative day 4, which necessitated surgical closure. However, in a long-term follow-up of 5 years, surgical access site herniation was observed in 5 (16.1%) LTLA versus 0 (0%) PRA patients (P = 0.022) and the need for hernia repair was noted in 4 (12.9%) LTLA versus 0 (0%) PRA patients (P = 0.050). Herniation was identified after the mean time of 31.2 months following surgery (median: 36 months, range: 12-48 months, 95% CI: 14.2-48.2 months). Four of 5 patients with hernia were symptomatic and underwent surgical hernia repair. Detailed data are presented in Table 2 .
All 36 of 65 (55.4%) patients with hormonally active adrenal tumors in this study were biochemically cured after unilateral total adrenalectomy. However, of 14 patients with aldosteronomas, 15 with pheochromocytomas, and 7 with glucocorticoid adenomas, normalization of arterial pressure and the possibility of discontinuing all hypotensive medications was achieved, respectively, in 9/14 (64.3%), 13/15 (86.7%), and 3/7 (42.8%) patients. In all the remaining patients, however, postoperatively it was possible to decrease either the dosage or the number of administered hypotensive medications.
One year after the operation, 2 of 7 (28.6%) patients with preoperative fully symptomatic glucocorticoidism still required substitution therapy with adrenocortical hormones, whereas 2 years after surgery, the substitution therapy could have been discontinued in all the patients (Table 4 ). 
DISCUSSION
In this prospective RCT, for the first time, both short-term and long-term outcomes of PRA were compared to the outcomes of most commonly performed LTLA. Both approaches appeared to be safe, but the PRA technique turned out to be even more rewarding than LTLA in terms of shorter duration of surgery, lower blood loss, faster and less painful recovery, shorter hospital stay, improved costeffectiveness, and abolished risk of surgical access site herniation.
In 3 prospective RCTs hitherto published comparing short-term outcomes of retroperitoneoscopic versus laparoscopic adrenalectomy, no significant differences were found between both approaches in major endpoints, including duration of surgery, blood loss, analgesia requirements, length of hospital stay, and morbidity. 6, 23, 24 However, 2 of these RCTs reported a significantly shorter convalescence period, 23,24 whereas 1 RCT found shorter time to oral intake in the retroperitoneoscopic arm. 23 The major limitation of these studies is the low number of patients enrolled, which may have limited the statistical power to detect significant differences. Unfortunately, power calculation was not presented in any of these RCTs. In addition, in all these RCTs, the intervention in the retroperitoneoscopic arm was LRA with patients in a lateral decubitus position, and not PRA with patients in a prone position. This issue is of paramount importance, as in LRA, it is more challenging to dissect the adrenal gland, which is hidden behind the superior pole of the kidney, whereas PRA offers a more ergonomic and direct access to the retroperitoneal space harboring the adrenal gland. It is surprising, but in 2 of 3 hitherto published meta-analyses comparing retroperitoneal to laparoscopic adrenalectomy both LRA and PRA were assigned to the same group of retroperitoneoscopic approach, which should be recognized as a selection bias leading to heterogeneity of the analyzed data and limited validity of the conclusions. 25, 26 A major benefit of PRA is avoidance of intra-abdominal dissection of adjacent organs and adhesions to expose the adrenal gland, as this technique offers direct access to the retroperitoneum. 14, 15 As a result, decreased operative time saved from directly accessing the retroperitoneum and the adrenal gland, and reduced blood loss reflecting minimized dissection were seen. On multivariable analysis, BMI of more than 30 kg/m 2 , and LTLA approach predicted the prolonged duration of surgery of more than 90 minutes (Table 3 ). Despite the fact that adrenal surgery in patients with glucocorticoid adenoma or pheochromocytoma is considered to be technically more challenging and hence longer-lasting than operations for nonfunctioning adrenal tumors, duration of surgery in this study was significantly influenced by BMI of more than 30 kg/m 2 , but not the functional status of the adrenal lesion. In addition, surgical access to the retroperitoneum via the lumbar region having reduced skin innervation, the use of only 3 ports (without the fourth port usually necessary during LTLA for liver retraction), avoiding the pneumoperitoneum, and avoiding intra-abdominal dissection resulted in faster and more comfortable postoperative recovery in the PRA group: lower postoperative pain (both at rest and on movements), lower prevalence of shoulder-tip pain, a lower additional analgesia request rate, a reduced potential for nausea, and no clinically relevant postoperative paralytic ileus. Thus, it is not surprising that in patients in the PRA group, time to oral intake, time to ambulation, and length of hospital stay were significantly shorter than in the LTLA group. The validity of these observations is high, as patients in both groups were encouraged to drink, eat, and ambulate as early as possible on the day of the operation soon after returning from the recovery room, whereas the patients, nurses, and outcomes-assessing clinical investigators were blinded to the relevant group assignment. Moreover, in a 5-year follow-up, the direct access to the retroperitoneum via trocar port placement in the lumber region in the PRA technique was associated with an abolished risk of surgical access site herniation and subsequent hernia repair. Those patients who experienced herniation in the LTLA group had BMI of more than 30 kg/m 2 , had bigger tumors requiring widening of the abdominal incision for removal, or both. Since its standardization in recent years, 9, [14] [15] [16] PRA has gained an increasing popularity among endocrine surgeons worldwide, who advocate that this approach should be the procedure of choice for the vast majority of adrenal surgery, which is undertaken in 80% of cases for small-and medium-sized benign adrenal tumors. 15, 16, 18, 19, 21 This belief is now supported by outcomes of this prospective randomized study showing the superiority of PRA over LTLA with respect to many clinically important outcome measures, including improved cost-effectiveness. Nevertheless, PRA is technically challenging at the beginning due to the necessity of operating in a considerably smaller operative field as compared to the LTLA approach and the need to operate in a reversed surgical field, what hinders the sense of direction. [16] [17] [18] [19] [20] [21] The ability to visit a center with expertise in the technique is crucial for successfully adopting this method of adrenalectomy. 16, 21 Continued mentorship during the introductory phase of PRA makes the operation easy to master and safe during the "learning curve" period, which is short and does not exceed the time needed to perform 20 operations. 16, 28, 29 Since PRA is an attractive alternative to LTLA, both techniques should be included in the armamentarium of surgeons who perform adrenalectomy routinely. We believe that PRA should be included in the curriculum for clinical fellows in endocrine surgery, but not necessarily trainees in general surgery, who will rarely approach adrenal tumors in their surgical career. At our institution, following the completion of this study, the PRA approach is the preferred operation for adrenal lesions less than 7 cm in size, whereas the LTLA approach is reserved for tumors larger than 7 cm in diameter. A background in endoscopic surgery, careful patient selection, and a high patient volume are keys to successful minimally invasive adrenal surgery. 30
CONCLUSIONS
This study demonstrated that both PRA and LTLA approaches were equally safe. However, the outcomes of PRA operations were superior to LTLA in terms of shorter duration of surgery, lower blood loss, lower postoperative pain, faster recovery, improved costeffectiveness, and abolished risk of surgical access site herniation.
DISCUSSANTS L. Fernández-Cruz (Barcelona, Spain):
Congratulations to the authors of this well-conducted study. Laparoscopic lateral adrenalectomy has become the standard for benign adrenal tumors. An alternative minimal approach is the retroperitoneoscopic adrenalectomy, either postlateral or the full posterior technique, as described by Martin Walz, in Germany.
In the present report, the authors tried to test, whether the PRA is superior to LTLA. In this study, the authors have observed that the duration of the retroperitoneoscopic adrenalectomy has a significantly shorter operating time. Secondary endpoints were identified in favor of a PRA. These were intraoperative blood loss, diminished pain intensity, a lower prevalence of shoulder-tip pain, less frequent additional analgesia request, a lower prevalence of nausea, a shorter time to oral intake, a shorter time to ambulation, and a shorter length of hospital stay.
However, to date, 3 prospective randomized trials have compared laparoscopic retroperitoneoscopic adrenalectomy with transperitoneal laparascopic adrenalectomy. No difference was found between the techniques, in terms of blood loss, complication rates, and analgesic requirements or the length of hospital stay, during the operation.
In addition, all these short-term operative outcomes showed no differences in recent systematic reviews and meta-analyses. Did you compare your results with the report on randomized control trials and try to elucidate these differences in the short-term outcomes, in favor of retroperitoneoscopic adrenalectomy?
The operative time in this report is rather short, using retroperitoneoscopic adrenalectomy; half as was reported by the MD Anderson Cancer Center series, but very similar to the Essen series, reported by Walz, who should be congratulated on this. It may be that the number of patients with Cushing's Syndrome, in this paper, represent only 12% of the series of retroperitoneoscopic adrenalectomy. It is well known that patients with cortisol excess have fibrotic glands nestled with copious fat, in a background of very fragile tissue, which require a meticulous operation. In this sense, the group of patients with pheochromocytoma represents only 24% of this series of retroperitoneoscopic adrenalectomies. Pheochromocytoma patients need the attention of the anesthesiologist to control the hemodynamic changes, in addition to that of the surgeons to control the vascularity of the glands. Usually, the operative time is greater, when compared to that of adrenal surgery for nonfunctioning tumors. Finally, what is reasonable in this paper is the comparison with the 5-year follow-up between retroperitoneoscopic adrenalectomy and LTLA. The authors have found that herniation occurs more often after LTLA than with retroperitoneoscopic adrenalectomy: 16% versus 0%.
However, the authors did not mention which methods were used to identify trocar site herniation, and whether the patients all had the same method of diagnosis-ultrasound, CT scan, and so forth. How many patients were symptomatic and when was the diagnosis of a trocar site herniation made in the postoperative period?
Response From M. Barczyński (Krakow, Poland):
Thank you for your excellent questions. First of all, I would like to address the issue of the 3 randomized studies, which have been published. The first, published in 1996, studied 11 patients and 20 operations, 10 of which were in the retroperitoneoscopic arm and 10 in the laparoscopic arm; as such, it was a small study. The other 2 studies were also small, namely 15 versus 15 interventions in the smaller one and 30 versus 30 operations in the larger one. In all of these randomized trials, the retroperitoneoscopic approach was a lateral one; it was not a posterior technique. In my experience, this is a crucial difference, as a posterior operation offers direct access to the adrenal gland, which makes the operation very easy and fast. A lateral retroperitoneoscopic approach offers less ergonomic access to the adrenal gland, due to the necessity to dissect the adrenal tumor, hidden behind the kidney. This differs from the posterior technique. So, I believe that this issue is of paramount importance and it is not recognized in 2 of the 3 previous meta-analyses.
Regarding your second question about the MD Anderson Cancer Center's longer duration of surgery, the answer is that they described the initial series of patients during the introductory phase of this technique in a different hospital, whereas we had this introductory phase completed before we started the randomized control trial. So, we were "grown up" in performing this technique, before we started the trial, whereas the MD Anderson Cancer Center's series was still on the steep portion of the learning curve.
To answer your third question, the number of patients with functional tumors in this study was 55%, of which 15 had pheochromocytoma, 7 had ACTH-independent Cushing's syndrome, and 14 had aldosteronoma, which were equally distributed within the 2 groups. So, there were no significant differences in baseline characteristics. I think that it is a fair comparison, concerning the operative time and the duration of surgery. We have not observed that functioning tumors had a longer operative time in our material, both using retroperitoneoscopic or laparoscopic technique.
In response to your last question, herniation was found in up to 16% of the patients, following laparoscopic adrenalectomy. The mean time of herniation was 3 years after surgery, ranging from 1 to 4 years after the operation. All hernias were in patients in the laparoscopic arm. As I mentioned, we were not using morcellation. If we were using morcellation in our study, perhaps you would have had a much lower number of patients with herniation. However, in a multivariable analysis, a BMI higher than 30 kg/m 2 and tumors larger than 4 cm were independent risk factors for herniation. For the diagnosis of herniation, as I mentioned, we used clinical criteria, meaning physical examination, and in doubtful cases, ultrasound, to confirm or rule out the existence of the hernia.
Thank you very much for your comment.
DISCUSSANTS F. Pattou (Lille, France):
I have 2 brief questions. The first one concerns the indications. For nearly 40% of the patients enrolled in your study, the final diagnosis was a benign nonfunctioning tumor. So, what was the indication for surgery in these patients? My second question is about teaching and the learning curve of the retroperitoneal approach. In our department, we have been performing laparoscopic adrenalectomy using the transperitoneal approach for 20 years, the first one having been performed by the first discussant and my predecessor, Professor Charles Proye, in January 1994. More than 500 cases have been operated so far, and most of these were done using the transperitoneal approach. You said that the posterior approach is technically more demanding, and indeed, we think that it is much more difficult to teach. In our experience, less than 20 procedures appear sufficient to master this technique. As such, what do you believe to be the learning curve for mastering this technique?
Response From M. Barczyński (Krakow, Poland):
Thank you very much for your good questions. In terms of the indications, 40% of the patients had nonfunctioning adrenal tumors; as such, the major indication in these patients was a tumor larger than 4 cm-between 4 and 7 cm-which has some considerable risk of malignancy. As such, our endocrinologists simply prefer to get rid of the tumor. For the other portion of the patients, to be referred for surgery at our center, the indication is an enlarging tumor-any tumor that is enlarging more than 1 cm, during the 6-month follow-up.
Regarding experience, I said that around 20 operations of the posterior technique are necessary to master this procedure, to operate under than 90 minutes. We published on this, comparing outcomes of the initial 50 operations, performed in Krakow, 10 years ago, during the introductory phase at our institution, to outcomes of initial 50 posterior operations performed in Essen, during the invention phase of this technique, by Martin Walz, less than 20 years ago. So, this estimation is based on our data published in the World Journal of Surgery in 2007.
In terms of the laparoscopic technique, I believe that 10 operations are, perhaps, not enough, as these operations are completely different between the right and left sides. As such, I believe that a larger number is needed to leave the steep portion of the learning curve for the lateral transperitoneal adrenalectomy.
